novo nordisk semaglutide pill Starter dose of Wegovy now available as a daily instead of weekly injection The Weight-Loss Drug Wegovy Now

The ACP recommends treating Type 2 diabetes using GLP-1 agonists to reduce the risk for all causes of death, major adverse cardiovascular events and stroke, and it recommends using SGLT-2s to reduce the risk for all causes of death, major adverse cardiovascular events, progression of chronic kidney disease and hospitalization due to congestive heart failure, according to a new study published in the Annals of Internal Medicine

Key Benefits: Skin Brightening: Glutathione, a powerful antioxidant, plays a crucial role in skin lightening by inhibiting melanin production

The choice between these two often comes down to your primary concern

Outcomes were assessed within a 2-year window after the index event